Long-term QUILT-3.032 findings show durable responses with Anktiva plus BCG in BCG-unresponsive NMIBC, with an estimated 84.2% cystectomy-free survival at 3 years. Nogapendekin alfa inbakicept ...

At a median follow-up of 60.9 months, median EFS was 74.1 months in the pembrolizumab arm and not reached in the placebo arm. The phase 1/2 CELC-G-201 study found preliminary antitumor activity and ...

Engy Habashy, MD, discusses key takeaways from the 2025 AUA GSM guideline, including the role of androgens and hormonal therapies in managing genitourinary syndrome of menopause.

The phase 3 BiPASS trial is evaluating the use of 68Ga-PSMA-PET in combination with MRI for prebiopsy prostate cancer detection. In the phase 3 PACE-A trial, SBRT and prostatectomy showed similar ...

"Pediatric-type cancer diagnoses in adults are rare, and there are important differences in caring for children with genitourinary malignancies compared with adults," write the authors.

Pastuszak discusses the evolving nature of understanding how testosterone therapy post-radiation for prostate cancer may beneficial or harmful to patients, and how to navigate the decision. Overall, a ...

This digital series features articles and videos with insights and expert viewpoints on PSMA-PET and the evolving imaging paradigm that is revolutionizing the diagnosis and treatment of patients with ...

Technological advancements in sacral neuromodulation include MRI-conditional devices, rechargeable systems, and extended battery lifespans, enhancing patient eligibility and reducing procedural ...

Pre-operative counseling should frame vasectomy as intended permanent contraception, individualized to reproductive goals, and can be delivered virtually or in person while directly addressing ...

LiSWT and PRP independently and combined significantly improved IIEF scores in ED treatment compared to control therapy. LiSWT was the most effective standalone treatment, with a mean IIEF score ...

177Lu-PSMA-617 added to ADT and ARPI significantly improved rPFS in patients with PSMA-positive mHSPC, with consistent benefits across subgroups. The PSMAddition trial showed a trend toward improved ...

From baseline to 1 year, the Ki-67 index decreased in the dietary intervention cohort by 15% and increased in the control cohort by 24%. Data from the phase 2 CAPFISH-3 trial show that a high omega-3, ...